Two fine pieces from this week's National Review Online
"Entrepreneurs Under Attack"

Why we have horse races

Jim Jubak, 9/23: "Be ready for the rally's end".

Steven Pearlstein, 9/24: "Yes, it may finally be time to get back into stocks".

One more:

Mad Money, 9/23:

What investors should do then, Cramer said, is review their portfolios right away . . . They’re the companies with less-than-stellar fundamentals whose stocks have performed well regardless. Think accidental high-yielders like Johnson & Johnson . . . which used to offer an attractive 4% yield that has since slipped to 3.5%. As far as Cramer’s concerned, the underlying business isn’t strong enough to justify owning the stock anymore.

Anand Chokkavelu, Motley Fool, 9/24:

Johnson & Johnson is a robust global health care play that is trading for around 11 times trailing free cash flow and is throwing off a 3.5% dividend yield. At current prices, I believe Johnson & Johnson is a solid addition to your portfolio's core. And I'm not the only one. It's recently been picked in our 50 Stocks in 50 Days series, Warren Buffett's Berkshire Hathaway (NYSE: BRK-B) has been loading up on the shares, and our CAPS community gives it the maximum 5 stars.